Genomma Lab named Rodrigo Herrera interim CEO and Genomma Lab stock costs EUR 0.64

Published on 10/13/2026 at 12:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached MXN 4.40 billion, while net income was MXN 374.49 million. Genomma Lab stock costs EUR 0.64 on October 13, 2026.

Key points in brief

Genomma Lab named Rodrigo Herrera interim CEO effective January 1, 2027.
The mandate is planned for 12 to 18 months and centers on a new operating model.
Second-quarter revenue reached MXN 4.40 billion and net income was MXN 374.49 million.
Genomma Lab stock was trading at EUR 0.64 at Lang & Schwarz on October 13, 2026.

Genomma Lab, MX01LA010006, Illustration mit AI erstellt.

Genomma Lab (MX01LA010006) was trading at EUR 0.64 at Lang & Schwarz on October 13, 2026, at 12:02 p.m. CEST. The company had named Rodrigo Herrera Aspra interim CEO effective January 1, 2027, according to Yahoo Finance on September 17, 2026.

Three dated company events

On September 17, 2026, Genomma Lab announced Herrera's interim appointment and a 12 to 18-month mandate. On September 22, 2026, the company declared a dividend of MXN 0.20 per share totaling MXN 200.0 million, according to PR Newswire. On October 1, 2026, Genomma Lab announced its third-quarter results date for October 21, 2026, according to Morningstar.

What changes on January 1?

Herrera is set to lead the transition while remaining chairman, with the board searching for a permanent successor. The operating plan covers 18 countries and combines product launches, marketing, supply and finance through an artificial intelligence platform, according to Yahoo Finance.

Upcoming dates carry the next test

Genomma Lab is scheduled to report third-quarter 2026 results on October 21, 2026, after the Mexican Stock Exchange closes. The company plans its conference call for October 22, 2026, at 11:00 a.m. Mexico City time, according to Morningstar. The two dates give investors a defined checkpoint for the new operating strategy.

Q2 numbers frame the transition

In the second quarter of 2026, revenue reached MXN 4.397 billion, up from MXN 4.191 billion in the previous quarter, while net income fell from MXN 494.647 million to MXN 374.493 million, according to Investing.com. The revenue comparison points to sequential expansion, while the profit decline makes execution and cost control important measures for the coming leadership transition.

Stock quote stays at EUR 0.64

At 12:02 p.m. CEST on October 13, 2026, Genomma Lab stock was trading at EUR 0.64 at Lang & Schwarz. The Mexican listing is LABB on the BMV, while the euro quotation is the reference for German investors in this article. The further course of trading is shown by the continuously updated real-time quote of Genomma Lab stock.